| Enzymatic Generation of Double‐Modified AdoMet Analogues and Their Application in Cascade Reactions with Different Methyltransferases M Erguven, NV Cornelissen, A Peters, E Karaca, A Rentmeister ChemBioChem 23 (24), e202200511, 2022 | 4 | 2022 |
| How Far Are We from the Rapid Prediction of Drug Resistance Arising Due to Kinase Mutations? M Erguven, T Karakulak, MK Diril, E Karaca ACS omega 6 (2), 1254-1265, 2021 | 4 | 2021 |
| Post-synthetic benzylation of the mRNA 5′ cap via enzymatic cascade reactions NV Cornelissen, R Mineikaitė, M Erguven, N Muthmann, A Peters, ... Chemical Science 14 (39), 10962-10970, 2023 | 2 | 2023 |
| Visible Light Activates Coumarin‐Caged mRNA for Cytoplasmic Cap Methylation in Cells A Bollu, H Schepers, N Klöcker, M Erguven, AM Lawrence‐Dörner, ... Chemistry–A European Journal 30 (2), e202303174, 2024 | 1 | 2024 |
| Genetic complementation screening and molecular docking give new insight on phosphorylation-dependent Mastl kinase activation M Erguven, S Kilic, E Karaca, MK Diril Journal of Biomolecular Structure and Dynamics 41 (17), 8241-8253, 2023 | 1 | 2023 |
| Genetic dissection of the Mastl-Arpp19/Ensa-PP2A-B55δ pathway in mammalian cells MK Diril, M Erguven Turkish Journal of Biochemistry 48 (2), 190-202, 2023 | 1 | 2023 |
| Complementation cloning identifies the essentials of mammalian Mastl kinase activation M Erguven, E Karaca, MK Diril bioRxiv, 2020.06. 30.179580, 2020 | 1 | 2020 |
| Benchmarking the accuracy of structure‐based binding affinity predictors on Spike–ACE2 deep mutational interaction set B Ozden, E Şamiloğlu, A Özsan, M Erguven, C Yükrük, M Koşaca, ... Proteins: Structure, Function, and Bioinformatics 92 (4), 529-539, 2024 | | 2024 |
| How far are we in the rapid prediction of drug resistance caused by kinase mutations? M Erguven, T Karakulak, MK Diril, E Karaca bioRxiv, 2020.07. 02.184556, 2020 | | 2020 |
| Investigating the determinants of mammalian Mastl kinase activation M Erguven, MK Diril | | |
| Supporting Information How far are we from the rapid prediction of drug resistance arising due to kinase mutations? M Erguven, T Karakulak, MK Diril, E Karaca | | |
Kasim DirilIzmir Biomedicine and Genome Center, Dokuz Eylul UniversityVerified email at deu.edu.tr
